La regeneración del músculo esquelético y los síntomas de la incontinencia urinaria por esfuerzo en una investigación preclínica indican una mejora tras el uso de una sustancia acelular descubierta en Mayo Clinic. Los equipos del Dr. en Ciencias Atta Behfar y del Dr. Emanuel Trabuco encabezaron esta investigación en una colaboración entre los Departamentos de Medicina Cardiovascular y de Obstetricia y Ginecología de Mayo Clinic. El artículo se ha publicado en NPJ Regenerative Medicine.
Músculo esquelético regenerado e sintomas de incontinência urinária por esforço em pesquisa pré-clínica sugerem melhora após o uso de uma substância livre de células descoberta na Mayo Clinic. As esquipes do Dr. Atta Behfar, Ph.D. e do Dr. Emanuel Trabuco lideram a pesquisa em uma colaboração entre os Departamentos de Medicina Cardiovascular e de Obstetrícia e Ginecologia da Mayo Clinic. O artigo foi publicado na revista NPJ Regenerative Medicine.
Molecular biologist Yu Xin (Will) Wang, Ph.D., has joined Sanford Burnham Prebys as an assistant professor in the Development, Aging, and Regeneration Program to uncover the ways muscle, nerve and immune cells work together to overcome disease.
Leprosy is one of the world’s oldest and most persistent diseases but the bacteria that cause it may also have the surprising ability to grow and regenerate a vital organ.
The Regenerative Medicine Development Organization (ReMDO) and analytics leader SAS are collaborating on the ReMDO RegeneratOR Test Bed, a novel regenerative medicine endeavor in North Carolina.
Cedars-Sinai has been awarded a five-year, $8 million grant from California’s stem cell agency to launch an innovative new clinic that will expand patients’ access to stem cell and gene therapies, increase research and training in regenerative medicine, foster greater collaboration with eight similar clinics across the state and help educate the public about stem cell and related therapies.
The New York Stem Cell Foundation (NYSCF) announced Dr. Derrick Rossi, a member of the NYSCF Board of Directors and co-founder of Moderna, as Interim CEO of NYSCF.
The discovery that different bone-forming stem cells are responsible for different aspects of bone maintenance and repair will allow us to focus future bone regeneration efforts
A new master’s degree program to prepare next and future generations of STEM professionals and business leaders for the regenerative medicine field has been established at the Wake Forest University School of Medicine in collaboration with regenerative medicine experts at the Wake Forest Institute for Regenerative Medicine (WFIRM).
Scientists at the UNC School of Medicine have made a significant advance in the promising field of cellular reprogramming and organ regeneration, and the discovery could play a major role in future medicines to heal damaged hearts.
Research from the Reik lab at the Babraham Institute has advanced our understanding of the role of DNA methylation during the earlier stages of development.
A Mayo Clinic está usando a impressão 3D como uma nova opção para cura de laringe após câncer ou lesão traumática. O Dr. David Lott, M.D., otorrinolaringologista e cirurgião de cabeça e pescoço da Mayo Clinic, é um especialista que pode falar sobre o procedimento pioneiro que usa engenharia de tecidos e bioimplantes 3D para regeneração de laringe, também conhecida como caixa de voz.
فينيكس ، أريزونا — تستخدم Mayo Clinic الطباعة ثلاثية الأبعاد كخيار جديد وعنق Mayo لعلاج الحنجرة بعد السرطان أو الصدمة. ديفيد لوت ، دكتوراه في الطب ، اختصاصي طب الأنف والأذن والحنجرة وجراح رئيس كلينك ، هو خبير يمكنه التحدث عن إجراء رائد يستخدم زراعة حيوية ثلاثية الأبعاد وهندسة الأنسجة لتجديد الحنجرة ، والمعروف أكثر باسم صندوق الصوت.
A team of scientists from the National University of Singapore has devised a novel technique of using magnetic pulses to grow cultured meat. When animal cells are exposed to a pulsed magnetic field, they release growth-inducing molecules to help them proliferate, without the need for animal serum. This approach is slaughter-free, greener, cleaner, safer and cheaper.
Mayo Clinic usa impresiones tridimensionales como una nueva opción para restablecer la laringe después del cáncer o de un traumatismo. El Dr. David Lott, otorrinolaringólogo y cirujano de cabeza y cuello en Mayo Clinic, es un experto que puede hablar acerca de un procedimiento pionero que usa implantes biológicos trimensionales e ingeniería de tejidos para regenerar la laringe.
New study data shows that the immuno-oncology drug, atezolizumab is a safe and effective treatment for stage IB-IIIB non-small cell lung cancer patients prior to lung cancer surgery, according to a new study led by researchers with The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute as part of the national Lung Cancer Mutation Consortium 3 study.
Researchers found that the survival of patients in this new study was far better – about 80% at three years post treatment and approximately twice as good as that which would be expected with surgery and chemotherapy alone. Study investigators also report data showing that the presence of high numbers of natural killer (NK) cells – a type of immune cell found in the blood before treatment – were associated with poor immunotherapy treatment effectiveness in this study. Patients with high levels of these cells might benefit from the addition of NK-specific therapy.
MIMEDX is the latest addition to the RegeneratOR Innovation Accelerator, located in the Regenerative Medicine Hub (RegenMed Hub), a rapidly growing regenerative medicine ecosystem based in the Innovation Quarter of Winston-Salem.
مايو كلينك رائدة في تحسين الإجراءات التجديدية التي تشكل جسرًا إلى عملية الزراعة. حيث توفر هذه الإجراءات خيارات جديدة لتقوية الصحة وإعادة بنائها بينما ينتظر المرضى هبة الحياة.
Unknown to passersby, a modest little creature with amazing abilities lives and breeds in the forests and paddy fields of Japan. Now, researchers from Japan have discovered how these amphibians' superpowers are unleashed.
RTT Medical is the newest tenant of the Innovation Accelerator, a support ecosystem created by the RegenMed Development Organization (ReMDO) to help companies with new or emerging regenerative medicine technologies speed up the translation of products to patients.
مدينة روتشستر، ولاية مينيسوتا: يعد تموز/يوليو هو شهر التوعية بالساركوما وللفت الانتباه لمجموعة من السرطانات التي تبدأ في العظام أو الأنسجة الرخوة في الجسم. هناك أكثر من 70 نوعاً من الساركوما، منها سرطان العظام. وتشمل طرق علاج سرطان العظام الجراحة والعلاج الكيميائي والعلاج الإشعاعي والعلاج الإشعاعي بحزم البروتونات الذي يستهدف الخلايا السرطانية.
Julio es el mes para concienciar sobre el sarcoma y llamar la atención sobre aquel grupo de cánceres que empiezan en los huesos o en los tejidos blandos del cuerpo. Hay más de 70 tipos de sarcoma, entre ellos, el cáncer de hueso.
Julho é o Mês da Conscientização do Sarcoma, chamando a atenção para um grupo de cânceres que começa nos ossos ou nos tecidos moles do corpo. Existem mais de 70 tipos de sarcoma, incluindo o câncer ósseo.
Scientists from the RIKEN Center for Integrative Medical Sciences in Japan in collaboration with other researchers from around the world have discovered that recombinations of specific genomic sequences that are repeated millions of times in the genome of each of our cells are pervasively found in both normal and in disease states. Identifying the mechanisms that lead to this myriad of recombinations involving DNA sequences that were once considered as “junk”, may be crucial to understanding how our cells develop and what can make them unhealthy.
Eliksa Therapeutics, a regenerative medicine company developing novel therapeutics for a range of debilitating diseases, announced today it has launched with investments from the University of Utah (U) and Militia Hill Ventures (MHV) to develop and commercialize multiple clinical programs using the regenerative medicine technology developed at the U.
Key takeaways:
• Just like the real thing. The stem cell–derived interneurons, which play a role in sensations like touch and pain, are indistinguishable from their real-life counterparts in the body.
• Tomorrow’s therapies. In addition to potential treatments for injury-related sensation loss, the discovery could lead to new methods for screening drugs for chronic pain.
• Moving forward. While stem cells from mice were used in the research, scientists are now working to replicate the findings with human cells.
Data collected by researchers at the Johns Hopkins Kimmel Cancer Center and the Bloomberg~Kimmel Institute for Cancer Immunotherapy suggest that Clostridioides difficile, or C. diff, a bacterial species well known for causing serious diarrheal infections, may also drive colorectal cancer.
مدينة روتشستر، ولاية مينيسوتا— في إحدى الدراسات الأولى من نوعها، حللت مايو كلينك مجموعة كبيرة من المرضى لفهم دوافعهم للبحث عن علاجات بالخلايا الجذعية وما إذا كانت التوقعات مبنية على العلم. ويمكن أن تساعد هذه النتائج خبراء الرعاية الصحية على التعامل مع الادعاءات المضللة وتقديم المشورة للمرضى بشكل أفضل.
Scientists from the University of Birmingham have shown that a brain-penetrating candidate drug currently in development as a cancer therapy can foster regeneration of damaged nerves after spinal trauma.
The human liver has amazing regeneration capabilities: Even if up to 70 percent of it is removed, the remaining tissue can regrow a full-sized liver within months.
Karallief® Inc., a leading nutraceutical ingredient company that researches, develops, and distributes clinically studied herbal extract ingredient formulas, announced today that the United States Patent and Trademark Office (USPTO) has granted U.S. Patent No. 11,364,255 for Karallief® Easy Climb®.
Researchers at Ruhr-Universität Bochum have been studying the role of the two proteins tenascin C and tenascin R in multiple sclerosis. In this disease, cells of the immune system destroy the myelin sheaths, i.e. the sheaths of the nerve cells.
Researchers have developed a unique 3D printed system for harvesting stem cells from bioreactors, offering the potential for high quality, wide-scale production of stem cells in Australia at a lower cost.